Zaleplon (Zalpilo (10 mg)) is a sedative/hypnotic, prescribed for insomnia. The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to ...

Learn everything you need to know about Zaleplon-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

Zaleplon, USP is a nonbenzodiazepine antihypertensive from the pyrazolopyrimidine class. Ink disadvantages are: shellac, dehydrated alcohol, isopropyl alcohol, general alcohol, propylene glycol, ...

As described above, comparison with zolpidem and triazolam shows that zaleplon has both a more rapid onset of effect and a shorter elimination half-life, [27] properties that allow for more ...

PITTSBURGH The Food and Drug Administration has granted final approval for Mylan subsidiary Genpharm’s application for 5mg and 10mg Zaleplon Capsules, Mylan announced Monday. Zaleplon Capsules are a ...

Eligible to serve as subjects were healthy, nonsmoking men who were between 18 and 45 years of age and within 15% of their ideal body weight. Candidates were excluded if they had donated blood within ...

Zaleplon exposure was dose proportional across the 4 doses studied, as calculated by power analysis. Pharmacodynamics, measured as sedation assessed on a 100 mm visual-analog scale, showed onset of ...

Zaleplon, zolpidem and zopiclone (the Z-drugs) are nonbenzodiazepine hypnotics. Although the Z-drugs differ structurally from the benzodiazepines, they are also agonists of the GABA receptor complex ...

Sleepwalking, sleep-driving, and sleep-using-a-stove are not things that you want to do. Therefore, the U.S. Food and Drug Administration on Tuesday announced that eszopiclone, zaleplon, and zolpidem ...

Certain commonly used sleeping pills will now contain a new boxed warning alerting patients to possible serious or life-threatening behaviors that may result from taking these drugs, the US Food and ...

The Assessment Report reviewed data from 24 randomised controlled trials (RCTs) that compared the Z-drugs with either a benzodiazepine or with another Z-drug in patients with insomnia. In total, 11 ...

MOUNTAIN VIEW, Calif., April 29 -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced positive results from a Phase 1 clinical trial of AZ-007 (Staccato(R) zaleplon). AZ-007 is an inhalation ...